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Introduction
Malaria is a mosquito-borne infectious disease transmitted by the 
bite of Plasmodium-infected female Anopheles mosquitoes, to verte-
brate hosts [1,2]. Malaria remains a major problem affecting humans 
today, with approximately half of the world’s population at risk [3]. 
Each year, Plasmodium falciparum (Pf) infects over 200 million people 
worldwide, and is responsible for an estimated 660,000 deaths, mostly 
of children under five years old. 80% of these deaths occur in sub-Sa-
haran Africa. 
The clinical manifestations of malaria are primarily due to schiz-
ont rupture, leading to destruction of erythrocytes (RBC), and vary in 
severity, which depends on host age, immune status, and strain of the 
parasite. Severe malaria is a multi-system disease caused almost exclu-
sively by untreated Pf infection. Cerebral malaria (CM) and anaemia 
are the two most common manifestations of severe malaria. CM is a 
syndrome characterised by unrousable coma and neurological sequel-
ae. The fine pathophysiological mechanisms underlying this neurologi-
cal syndrome are not fully understood, although several hypotheses 
have been put forward:
(i) The “mechanical” hypothesis, involving cell sequestration, the 
deformity of RBC and aggregation [1,4,5], 
(ii) The “immunological” hypothesis, attributing the development 
of infection to the stimulation of production and release of pro-inflam-
matory and anti-inflammatory cytokines [4,6,7], and 
(iii) A combination of these [8,9], being the most likely hypothesis, 
since each alone cannot fully explain all manifestations and clinical 
signs of CM [10]. 
Recently, emerging research has focused on miRNA to understand 
more about their roles in normal and pathophysiological conditions. 
miRNA are a type of single-stranded, non-coding RNA approxi-
mately 22 nucleotides in length, that function as post-transcriptional 
regulators of targeted gene expression in eukaryotes, thus regulating 
the translation of mRNAs and proteins. It is now known that miRNA 
play crucial regulatory roles in numerous biological processes, includ-
ing apoptosis, cell proliferation, metabolism, development, and differ-
entiation [11,12]. miRNA are also known to be involved in a broad 
range of infectious diseases and inflammatory pathologies. Recently, 
our understanding of the cellular and molecular networks that regu-
late inflammation has improved considerably, including the critical 
role miRNA play in managing features of the inflammatory process, 
often associated with a range of pathologies, including chronic inflam-
mation, autoimmunity, and cancer [13]. The dysregulation of miRNA 
in viral, bacterial, and parasitic diseases has been studied extensively 
[14-16], though few studies exist examining the role of miRNA in ma-
laria specifically. In this review, we address the ways in which parasite, 
vector, and host miRNA have been implicated in the pathogenesis of, 
or protective immunity against, malaria and the dynamic interactions 
between these three components in malaria transmission. As depicted 
in Figure 1, miRNA are present in each of the parasite, vector, and host, 
but a significant sharing of material exists between these entities, and 
this active sharing process of miRNA has a great impact on the trans-
mission and pathogenesis of, or protective immunity against, malaria.
miRNA in Host-parasite Interactions
Significant material exchange occurs between the host cell and Pf 
during the intraerythrocytic developmental cycle [17]. Xue et al. de-
tected the presence of human miRNA within the parasite; however, 
interestingly, they found no parasite-specific miRNA2, consistent with 
previous reports by Rathjen et al. [18]. Of the 132 short RNA found by 
Xue et al., 54 were rRNAs and tRNAs from human blood and Plasmo-
dium, 18 were degraded fragments of human blood and Plasmodium 
mRNA, 26 were human miRNA, and 24 did not match the human or 
Plasmodium genome. Notably, among the miRNA found in uninfected 
normal RBC, human miR-451 was significantly enriched in parasitised 
RBC (pRBC). 
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Abstract
Malaria is a mosquito-borne infectious disease caused by parasitic protozoa of the genus Plasmodium. It remains 
a major problem affecting humans today, especially children. However, the pathogenesis of malaria, especially severe 
malaria, remains incompletely understood, hindering our ability to treat this disease. Of recent interest is the role that 
small, non-coding RNAs play in the progression, pathogenesis of, and resistance to, malaria. Independent studies have 
now revealed the presence of microRNA (miRNA) in the malaria parasite, vector, and host, though these studies are 
relatively few. Here, we review these studies, focusing on the roles specific miRNA have in the disease, and how they 
may be harnessed for therapeutic purposes.
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LaMonte et al. investigated how human miRNA are translocated 
into the parasite, since Pf lacks orthologs of Dicer/Ago [19,20], in-
volved in the conventional mode of RNA interference, which occurs 
as follows: RNA interference (RNAi) is initiated by the enzyme Dicer, 
which cleaves dsRNA into shorter molecules that dissociate into ss-
RNA. One strand is degraded, and the other is incorporated into the 
RNA-induced silencing complex. If this strand pairs with a comple-
mentary sequence of mRNA, it is degraded by Ago. RNAi is impor-
tant in defending cells against parasitic nucleotide sequences.  Using 
Illumina deep sequencing, 5’ RACE PCR, and ribonuclease protection 
assays, LaMonte et al. confirmed that human miRNA transferred into 
the parasite formed chimeric fusions with Pf mRNA via impaired ribo-
somal loading, resulting in translational inhibition, eventually impair-
ing parasite biology and survival. It is not yet known what determines 
the specific enrichment of particular miRNA or their incorporation 
into specific parasite mRNAs.
Interestingly, La Monte et al. explored the protective immunity and 
resistance to Plasmodium conferred to RBC by human miRNA and the 
variant haemoglobin allele (HbS), that causes sickle cell disease [21]. 
In malaria-endemic regions, sickle cell disease occurs at relatively high 
frequencies [22,23], and mutations as part of this disease often provide 
protection against the malaria parasite [24]. This enhanced resistance is 
thought to be due, at least partly, to more rapid phagocytosis of pRBC 
by monocytes [25], suggesting that the parasite is more rapidly cleared 
by the immune system.
The presence of ~100 human miRNA was detected within the para-
sites, using multiplex real-time PCR, and, in pRBC, found similar en-
richment in miR-451 as well as miR-223 and miR-19b [2,21] confirm-
ing and expanding previous data [2]. Elevated levels of specific human 
miRNA were found in RBC with heterozygous  (HbAS) and homozy-
gous sickle cell haemoglobin (HbSS), when compared to normal RBC 
(HbAA), implying a functional role of these miRNA [21]. Specifically, 
miR-16 was present in abundant levels in HbAA RBC, and miR-181a 
had no effect upon parasitaemia, whereas transfection with miR-451, 
miR-223 or let-7i led to a markedly reduced percentage of pRBC in 
vitro. Combined transfection with miR-451 and miR-223 reduced the 
infection rate by 46%, with a similar effect seen for additional combina-
tion with let-7i. Increased parasite growth was observed in HbAS and 
HbSS pRBC due to the inhibition of host miRNA, specifically miR-451. 
HbAA pRBC showed almost no inhibition of miR-451, and no change 
in parasite growth. The expression of miR-451 was also examined in 
Plasmodium berghei-infected mouse RBC by Xue et al. [2], and found 
to also be independent of erythrocytic stage and parasitaemia, as shown 
in human erythrocytes by LaMonte et al. [21]. Potential gene targets for 
these miRNA include PKA-R (cAMP-dependent protein kinase) or are 
implicated in red cell remodelling. Therefore, miRNA-451 contributes 
significantly to malaria resistance, by the role played in the differentia-
tion and/or maturation of primary RBCs.
Together, these data confirm that human miRNA regulate proto-
zoan gene expression via cross-species chimeric transcripts, and raise 
the question of how erythrocyte miRNA modify parasite mRNAs. Ex-
amining further these seemingly independent mechanisms of parasite 
resistance will provide fresh insights into the complex relationship 
between the host genome and threatening microbial pathogens. In 
addition to this, further identification of targets genes will shed light 
on the biological roles of these miRNA of interest. However, what can 
currently be concluded is that the unidirectional exchange of miRNA 
from host to parasite protects the host by negatively affecting parasite 
survival.
 miRNA in Vector-parasite Interactions
miRNA in Anopheles gambiae mosquitoes play physiological and 
protective roles during Plasmodium infection. In the life cycle and 
transmission of the malaria parasite, the passage Plasmodium takes 
across the Anopheles midgut constitutes the major bottleneck. Re-
cently, research has focussed on the role of miRNA in regulating the 
Anopheles defence reaction. Studying interactions between the para-
site and insect vector provides an opportunity to identify methods to 
disrupt or reduce pathogen transmission.
Using a combination of shotgun cloning and bioinformatic analy-
sis, Anopheles mosquito miRNA were analysed, specifically their ho-
mology with other species and their localisation within the mosquito 
[26]. 152 clones were found that could be potential miRNA, however 
only eighteen met all the criteria to be bona fide miRNA. These eigh-
teen miRNA found in A. gambiae mosquitoes, included three unique 
to the strain. Twelve were expressed ubiquitously across the body, in-
dependent of gender, while the other six exhibited an expression pat-
tern restricted to the digestive system, including the three mosquito-
specific miRNA. Interestingly, the expression of four specific miRNA, 
again including the three unique miRNA, was affected by the presence 
of Plasmodium. Knocking down Dicer1 and Ago1 mRNAs via gene 
silencing techniques led to increased susceptibility of the mosquitoes to 
Plasmodium infection [26-28], therefore providing evidence for miR-
NA-mediated post-transcriptional regulation of the genes involved in 
defence reactions, as mosquito genes of the silencing pathway would 
affect parasite development in the midgut.
Xu et al. too examined the expression profile of miRNA in A. gam-
biae mosquitoes, and found 200 putative miRNA precursors expressed. 
Of these precursors, 78 encoded mature miRNA conserved in at least 
one other animal species [29]. In the Asian malaria mosquito, A. ste-
phensi, 23 conserved and four new miRNA sequences were identified. 
The expression profile of eight of these miRNA, including four miRNA 
unique to this mosquito strain, revealed distinct patterns from early 
embryo to adult stages in the mosquito development. For example, 
given the expression profile, miR-x-2 was likely involved in female 
reproduction, and consistent expression of miR-14 suggests its likely 
importance across all mosquito life stages [30]. 
During blood feeding, Plasmodium induces several host effector 
molecules in the mosquito. Blood feeding and parasitised blood feed-
Figure 1: Dynamic interactions between the parasite, vector, and host in ma-
larial infections. Cross-species interactions and regulation affects the trans-
mission and pathogenesis of, and/or resistance to malaria infections. (A) Hu-
man miRNA (e.g. miR-19b, -223, and -451) [2] and (C) mosquito miRNA (e.g. 
miR-34, -989, -1174, and -1175)26 affect malaria parasite biology and survival. 
(B) Parasite miRNA (e.g. miR-124, -305, and -309)31 regulate metabolic path-
ways in Anopheles mosquitoes. (D) Host miRNA (e.g. let-7i, miR-27a, -150,51 
-1274a42) regulate host gene expression.
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ing revealed regulation of 13 and 16 mosquito miRNA, respectively, for 
example miR-124, 305, and 309, which are known to target multiple 
genes in immune pathways. miRNA controlling metabolic, redox ho-
meostasis and protein processing pathways were down-regulated upon 
parasitised blood feeding. Another set of miRNA showed significant 
expression changes between 42 h and 5 days p.i. (coinciding with the 
late phase of midgut invasion by the parasite and initiation of sporozo-
ites release from the oocytes, respectively), indicating a parasite stage-
specific role of host miRNA [31]. Biryukova et al., too, showed a shift in 
miRNA expression following blood feeding and parasitised blood feed-
ing. They found 4 miRNA with a significant expression shift after blood 
feeding: miR-7, miR-92a, miR-317, and miR-N3; and 6 after parasit-
ised blood feeding, including miR-317, and miR-2940 [32]. Therefore, 
miRNAs that affect the development and maturation of the parasite 
within the mosquito are targeted, following a blood meal, indicating 
some mechanisms of survival and propagation of the parasite.
Understanding miRNA functions contributes to a better under-
standing of mosquito reproduction, longevity, and mosquito-pathogen 
interactions that might provide a revolutionary way to hinder malaria 
transmission. Further research will enhance this understanding, espe-
cially in terms of functional miRNA exchange between the parasite and 
vector, as well as the little explored topic of miRNA exchange between 
the vector and the target host.
Mammalian host miRNA
Evidence is accumulating that miRNA are critically implicated in 
the outcome of diseases, but little information is available regarding 
their mechanism of action in these cases. To date, Glinksy et al. are the 
only study to publish research regarding miRNA in human patients. 
Using PBMCs from malaria patients, they showed, using microarray 
analysis, that chloroquine therapy reversed the disease-associated phe-
notypes of nuclear import and inflammasome pathways [33]. Their 
analysis showed that miRNA and mRNAs controlling the Karyopherin 
Alpha 1 (KPNA1), and NLR family pyrin domains containing 1 and 
3 (NLRP1 and NLRP3) genes (inflammasome-related genes) showed 
changed levels of expression following chloroquine therapy: decreased 
expression of KPNA1 and NLRP1 during infection was reversed after 
chloroquine, and their expression was elevated by 66% and 13%, re-
spectively. Also, infection-induced increased expression of NLRP3 was 
reduced by 57% after chloroquine.
miRNA have been shown as key components, in the liver and 
elsewhere, in the immune response following malaria infection, with 
many miRNA known to control cell growth and proliferation, stress re-
sponses, and metabolism, as well as gene expression and susceptibility 
to infection [34-38]. The liver is a known anti-malaria effector organ, 
as the site of the pre-erythrocytic development of Plasmodium [39,40], 
where Kupffer cells and extrathymic lymphocytes are generated follow-
ing infection to carry out important protective immune functions, such 
as phagocytosis of pRBC [41]. 
Delić et al. examined miRNA expression in the liver of malarial-
infected mice and found a hepatic miRNA signature in female C57BL/6 
mice infected with self-healing P. chabaudi [42]. These mice displayed 
peak parasitaemia of approximately 50% on day 8 post infection (p.i.) 
and in 80% of cases these infections were self-healing. Among those 
mice that survived the initial infection, 100% survived subsequent chal-
lenges eight weeks later, with a peak parasitaemia of 1.5%. Liver miR-
NA profiles were analysed using miRXplore microarrays and quantita-
tive RT-PCR (qRT-PCR). The liver was found to respond to primary 
infections with an upregulation of three miRNA and a downregulation 
of sixteen other miRNA, some of which had known roles in apoptosis 
and cancer. Among them, the high expression of miR-1274a in the liver 
was confirmed by qRT-PCR. Surprisingly, a similar pattern of miRNA 
expression was found in immune mice, i.e. mice that survived the first 
infection, and also upon re-infection of these mice, suggesting that the 
modulations of expression of these miRNA are specific to the infection 
status irrespective of their levels. Interestingly, no changes in expres-
sion were detected of those miRNA currently known to be critically 
involved in adaptive immune responses, such as antibody formation, 
development, B cell maturation, and the formation of memory B cells, 
CD4+ T cells, and CD8+ T cells. Thus, the development of protective 
immunity against blood stages of P. chabaudi is associated with a re-
programming of the expression of distinct miRNA species yet to be 
identified in the mouse liver.
In another study, Al-Quraishy et al. tested testosterone-induced 
susceptibility to blood-stage malaria of P. chabaudi and measured the 
coinciding changes in miRNA expression of the anti-malaria effector 
sites, the spleen and liver [43]. Female C57BL/6 mice were treated with 
vehicle or testosterone for 3 weeks and, 12 weeks later, were challenged 
with P. chabaudi. miRNA expression was examined during testoster-
one treatment, after 12 weeks of testosterone withdrawal, and follow-
ing this, during infections at peak parasitaemia. Changes could be ob-
served in miRNA expression during testosterone treatment and after 
its cessation. For example, a specific upregulation during testosterone 
withdrawal was observed only in the spleen for miR-200a, and only in 
the liver for miR-142-5p and miR-342-3p. The latter two miRNA have 
been shown to be upregulated in cancer cells [44], leucocytes [45], in 
antigen-induced differentiation of T cells [46], and in B cell activation 
in leukemia [47,48], and the target genes of miR-342-3p are involved 
in different processes such as cell proliferation [44]. These results im-
ply an influx of cells expressing these two miRNA into the liver. Upon 
infection, however, these changes in miRNA expression were not 
maintained. Various changes were observed, notably a downregulated 
expression of most miRNA species by more than 2-fold in the spleen 
and liver. The same response to P. chabaudi malaria was observed in 
miRNA expressions in these two organs in testosterone-pretreated 
mice and vehicle-treated control mice. This change in expression sug-
gests that testosterone-induced susceptibility to P. chabaudi does not 
affect miRNA expression and, therefore, gene expression. This suscep-
tibility was shown to be irreversible, i.e. mice pre-treated with testos-
terone remained susceptible to infection after 12 weeks of withdrawal. 
This response to infection following testosterone treatment and subse-
quent withdrawal was also observed by Delic et al. [49]. This study went 
on to confirm that the testosterone-induced upregulation of specific 
miRNAs coincided with an at least 2-fold downregulation of some of 
their known gene targets. Altogether, the reprogramming of miRNA 
expression in the spleen and liver is essential for the development of 
protective immunity against blood-stage malaria, and that the respon-
siveness of this reprogrammed expression is not affected by testoster-
one-induced susceptibility.
Hentzschel et al. studied the role of miRNA in protection against 
liver stages of Plasmodium infection. Here, they examined the role 
specifically of miR-155 in mice infected with genetically attenuated 
parasites (GAP). Previously, it had been shown that GAP arrested in 
the liver, induce sterile immunity, but only after several administra-
tions. It was found that GAP-injected mice displayed a broad activa-
tion of IFNγ-associated pathways and a significant increase in miR-155 
within macrophages in the liver [50]. This upregulation enhanced the 
protective capacity of GAP substantially, highlighting the crucial role 
of mammalian miRNAs in Plasmodium liver infection.
The presence of miRNA was also associated with pathogenesis and 
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the development of the neurological syndrome in the murine model 
of CM. When animals are infected with Plasmodium berghei ANKA 
(PbA), they develop a neurological syndrome where the brain is the 
main targeted organ. El Assaad et al. examined the expression of a 
selection of miRNA, known to be associated with inflammation and 
infection, by qRT-PCR in the brain and the heart during malaria in-
fection with PbA, and compared it to a non-encephalitogenic strain 
Plasmodium berghei K173 (PbK)-infected CBA mice, as well as unin-
fected mice [51]. Significant changes were found in the expression of 
let7i, miR-27a, and miR-150 in the brain tissue of PbA-infected mice 
compared to uninfected mice at the time of the neurological syndrome. 
In contrast, no changes in these miRNA were detected in the heart, an 
organ with no known pathology, during CM [51]. Distinct expression 
profiles were observed in the brains of PbA- and PbK-infected and un-
infected mice. This difference in expression could not be attributed to 
parasite load, as mice showed comparable levels of parasitaemia. Using 
the miRBase database, predicted gene targets of the three miRNA show-
ing significant changes in CM regulate pathways involved in inflamma-
tion, innate pathogen recognition, apoptosis, and immune functions 
[52-54]. Both strains of parasite induced an increase in the expression 
of let-7i and miR-150 compared with the level in uninfected mice, with 
PbA inducing a greater response. The let-7 family has previously been 
shown to control cellular proliferation and innate immune responses 
[53,54], and miR-150 was highly expressed in monocytes and has been 
implicated in cell proliferation, development, and differentiation. This 
change in expression is crucial, as an accumulation of monocytes in the 
cerebral microvasculature has been associated with fatal murine CM 
[55]. The sequestration of monocytes within the cerebral microvessels 
of PbK-infected mice can still be observed, albeit at a lower level than in 
PbA-infected mice, and this is consistent with the changes in miRNA 
expression observed. Of the six selected miRNA, miR-27a expression 
was significantly increased in PbA-infected mice only, suggesting that 
it may have a more specific role in CM. miR-27a has been shown to 
induce apoptosis, disrupt mitochondrial membrane potential, increase 
sensitivity to TNF [56], and control the regulation of T cell prolifera-
tion and the NF-KB signalling pathway during inflammation [57]. 
Thus, overexpression of these three miRNA during PbA infection in 
mice may be critical for triggering the neurological syndrome. Since 
these altered expression levels coincided with increased apoptosis, and 
levels of circulating inflammatory cytokines in the brain, demonstrated 
by Lackner et al. [58], the regulation of potential targets of these miR-
NA appears crucial. 
Not only does malarial infection modulate particular sets of 
miRNA, but also the host genetic background may play a role in de-
termining a miRNA profile associated with CM. In these studies, the 
potential link between alterations in miRNA expression and malaria 
pathogenesis was explored and these alterations could be reversed fol-
lowing treatment, though evidence of this is only provided in the case 
of non-cerebral malaria.
Conclusions
The study of miRNA and their importance during malaria infec-
tion is at its beginning but is showing promise since miRNA have 
been shown to play roles in the resistance to and protective immune 
response against malarial infection, and in the pathogenesis of the in-
fection in some cases. These roles are not strictly limited to host miR-
NA acting within the host either as evidence of interspecies miRNA 
transcripts impairing the normal function of Plasmodium in order to 
confer resistance to the host were demonstrated. miRNA translocation 
is a dynamic process between parasite, host  and vector, allowing for 
the protective or pathogenic interactions between these elements of 
malarial transmission. Certain areas, such as the role of miRNA in the 
interaction between vector and host, have not yet been explored, and 
more data is needed to support the conclusions regarding the direct 
role miRNA play in host defence against Pf. Indeed, despite the role 
miRNA play in infection, whether pathogenic or protective, the mech-
anisms of action are still incompletely understood. This is partly due 
to the redundancy in the control of gene expression, where individual 
miRNA control numerous mRNAs, resulting in innumerable changes 
in gene expression. Therefore, to attribute one feature of the disease to 
a single miRNA is practically impossible. While some functional stud-
ies have been performed, linking miRNAs with target genes involved 
in malaria infection or pathogenesis, more research is needed in this 
area. In addition, unravelling the details of miRNA mechanism of ac-
tion during infection may give us more hints to understand malarial 
pathogenesis, serve as biomarkers for disease progression and, most 
importantly, be useful for developing therapeutic uses for miRNA or 
their inhibitors in patients with severe malaria.
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